MEAD JOHNSON & COMPANY
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 29, 2010 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,158 Total Citation Count
- Apr 02, 1975 Earliest Filing
- 81 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
4617291 Angiotensin-converting enzyme inhibiting dipeptide derivativesExpiredMay 14, 82Oct 14, 86[A61K, C07C, C07K]
4581357 Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compoundExpiredMar 26, 84Apr 08, 86[A61K, C07D]
4547358 Sustained release tablet containing at least 95 percent theophyllineExpiredJun 04, 84Oct 15, 85[A61K]
4524206 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivativesExpiredSep 12, 83Jun 18, 85[C07D]
4495352 Heterocyclic substituted aryloxy 3-indolyl-tertiary butylaminopropanolsExpiredDec 03, 81Jan 22, 85[A61K, C07D]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
